The cotreatment of TRAIL and neobavaisoflavone, an isoflavone isolated from Psoralea corylifolia, synergistically sensitized U373MG glioma cells to TRAIL-mediated apoptosis via the upregulation of DR5 expression. Here, TNFSF10 is linked to central nervous system cancer.